Lead Product(s): Nangibotide
Therapeutic Area: Trauma (Emergency, Injury, Surgery)
Highest Development Status: Phase II Product Type: Large molecule
Partner/Sponsor/Collaborator: Roche Diagnostics GmbH
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 21, 2020
Inotrem entered a worldwide licensing agreement with Roche Diagnostics for the commercialization of a mechanism-based companion diagnostic test using a soluble plasma protein.